Pediatric Genetic Counselor
Melody Perpich, M.S., C.G.C. is a board certified and licensed genetic counselor working in pediatric oncology, at The University of Chicago Medical Center, since April, 2016. She provides genetic counseling and cancer risk assessment to pediatric, young adult and adolescent patients with solid tumor and hematologic malignancies and their family members. She also provides genetic counseling to children at risk for an inherited cancer predisposition syndrome but do not have a cancer diagnosis. Prior to her current position, Ms. Perpich developed the Cancer Risk Evaluation Program at Creticos Cancer Center, Advocate Illinois Masonic Medical Center. She provided cancer genetics counseling and risk assessment regarding hereditary cancer susceptibility syndromes. Previously, Ms. Perpich worked at the University of Chicago for 10 years in the adult Cancer Risk Program, Advocate Illinois Masonic Medical Center for 10 years as a prenatal and preimplantation genetic counselor, and at the University of Illinois, Chicago as a pediatric and prenatal genetic counselor. Ms. Perpich completed her graduate training in genetic counseling at the University of Michigan, Ann Arbor in 1987. Ms. Perpich has a diverse background in prenatal, pediatric, preimplantation, and cancer genetics.
Ms. Perpich was education co-chair for the Cancer Special Interest Group of the National Society of Genetic Counselors and was previously a member of the Assisted Reproductive Technology Special Interest Group of the National Society of Genetic Counselors. Ms. Perpich is also a Professional Group Outreach and Provider Education (PGOPE) committee member for the Genetics Task Force of Illinois (GTFI). She is a member of the speaker’s bureau for the Bright Pink breast and ovarian cancer support organization. Ms. Perpich has been a supervisor and mentor for graduate students from the Northwestern University Genetic Counseling Program since 2000. Ms. Perpich has written and co-authored articles on a broad range of topics including; cancer genetics, preimplantation, and prenatal genetics.